Correlation Between Pliant Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Mersana Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Mersana Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pliant and Mersana is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 5.36 times less return on investment than Mersana Therapeutics. But when comparing it to its historical volatility, Pliant Therapeutics is 1.89 times less risky than Mersana Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 705.00 in Mersana Therapeutics on August 24, 2024 and sell it today you would lose (501.00) from holding Mersana Therapeutics or give up 71.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| Pliant Therapeutics |
| Mersana Therapeutics |
Pliant Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |